Fast concurrent determination of guaifenesin and pholcodine in formulations and spiked plasma using first derivative synchronous spectrofluorimetric approach

Aya Roshdy,Randa Abdel Salam,Ghada Hadad,Fathalla Belal,Heba Elmansi

DOI: https://doi.org/10.1002/bio.4660

IF: 2.613

2024-01-13

Luminescence

Abstract:Green first derivative synchronous spectrofluorometry was used for simultaneous analysis of guaifenesin and pholcodine at 283 nm for guaifenesin and at 275 nm for pholcodine using a wavelength difference (Δλ) of 40 nm; the procedure was successful in determining these drugs in vitro in spiked plasma samples. Guaifenesin and pholcodine are frequently co‐formulated in certain dosage forms. A new fast first derivative synchronous spectrofluorometric method has been used for their simultaneous analysis in mixtures. Here, first derivative synchronous spectrofluorometry enabled the successful simultaneous estimation of guaifenesin at 283 nm and pholcodine at 275 nm using a wavelength difference (Δλ) of 40 nm. The method was fully validated following International Council of Harmonization guidelines. For guaifenesin and pholcodine, linearity was determined within the corresponding ranges of 0.05–0.30 and 0.10–6.0 μg/ml. The two drugs were effectively analyzed using the developed approach in their respective formulations, and the results showed good agreement with those attained using reference methods. The method demonstrated excellent sensitivity, with detection limits down to 0.007 and 0.030 μg/ml and quantitation limits of 0.020 and 0.010 μg/ml for guaifenesin and pholcodine, respectively. Therefore, the procedure was successful in determining these drugs simultaneously in vitro in spiked plasma samples and syrup dosage form. The developed methodology also offered an environmentally friendly advantage by utilizing water as the optimal diluting solvent throughout the whole work. Different greenness approaches were investigated to ensure the method's ecofriendly properties.

chemistry, analytical